Phase 2a clinical trial of BrainStorm stem cell product shows ‘clinical benefit’ – Jerusalem Post
Jerusalem Post |
Phase 2a clinical trial of BrainStorm stem cell product shows 'clinical benefit'
Jerusalem Post Nearly all patients who underwent stem cell treatment for amyotrophic lateral sclerosis (ALS) developed by Brain- Storm Cell Therapeutics Inc. and tested in a Phase 2a clinical trial at the Hadassah University Medical Center in Jerusalem's Ein Kerem … Brainstorm Stem–Cell Therapy Continues to Show Treatment Effect in ALS Patients Israel's BrainStorm says stem cell drug benefits most patients in ALS trial |
